Notably, Wang and colleagues in 2014 reported that GSN may regulate the sensitivity to chemotherapy in patients with head-and-neck cancer [47], whereas more recently Zhao and colleagues have reported the GSN involvement in radio-resistant LC patients [48]. This evidence concerns the gene GSN and laryngotracheoesophageal cleft.